FCX vs INDP · P/E 38, rev $25.45B vs $7.4M cap
Freeport-McMoran Copper & Gold Inc (FCX) versus Indaptus Therapeutics Inc (INDP) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Indaptus Therapeutics Inc (INDP) is a biotechnology company listed on US.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
INDP does not have a complete income-statement cache yet.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. INDP currently screens at market cap $7.4M.
Not investment advice. Open the FCX and INDP stock pages for the full models.
Not investment advice.